New Method Could Reduce Costs and Meet Demand
Navix proposed to develop a single-step, homogenous, quantitative assay to detect specific DNA sequences using a process the company called Self-Detected Target-Cycling Reaction (SD-TCR). The proposed SD-TCR process would use a novel protein-assisted strand replacement reaction that incorporated into the assay a protein enzyme coupled to one strand of a DNA probe. This probe corresponded to the DNA sequence correlated with the disease of interest. When double-stranded DNA from a patient was introduced, the probe (covered with an enzyme that actively sought out target double-stranded DNA) would find and replace any areas in the patient's DNA that correlated with disease. This binding released the strand with the enzyme that, in turn, activated a second enzyme that would show as an amplified, colored diagnostic result. In short, if the color appeared, a mutation (or other sequence of interest) was present.
If successful, the SD-TCR process would dramatically reduce the number of required steps for typical DNA diagnostics to just one. Instead of the costly sample preparation steps, the Navix technology would not require any modification or manipulation of the sample DNA other than simple DNA isolation and its addition to the reaction chamber. After being added to the reaction chamber, the sample DNA would then be allowed to react at controlled temperatures for about an hour. If successful, the SD-TCR process would reduce the time required for DNA diagnostics from days to hours. Moreover, with the addition of a reaction chamber to the system, the cost of conducting a full test analysis would be dramatically reduced from hundreds of dollars per test to less than $1.
Navix Faces Technical Challenges
Navix's technical challenge was to coordinate the three distinct chemical reactions necessary for the SD-TCR technology into a single step. The reactions (DNA identification, amplification, and signal generation) were all possible when they occurred separately, but they needed to be integrated into a working system. Navix entered into a subcontractor agreement with Profile Diagnostics, Inc. to pursue integrating the three reactions. Both Navix and Profile Diagnostics had years of experience in optimizing stand-alone DNA identification, amplification, and signal generation reactions. Together, the team sought to create new DNA diagnostic protocols that would not require new automated instruments. Instead, they asked the question, What can an existing diagnostic laboratory accomplish, and how can we enable one-step DNA diagnostics with those materials?
Navix scientists believed that the materials in a DNA diagnostics laboratory could be integrated through two technically risky and complex steps. First, the scientists would have to compartmentalize and optimize the DNA identification and detection functions into different areas within the reaction chamber without risking contamination. Second, they would have to integrate the three different reactions so that each stage would be compatible with the others and there would be no possibility of premature signal color development that would lead to incorrect results. Navix proposed that they could tightly integrate these reactions in order to achieve a single-step, homogeneous DNA assay.
|